The United Laboratories International Holdings Limited 03933.HK 上一季度的收入表現如何?
The United Laboratories International Holdings Limited 的收入預期是多少?
The United Laboratories International Holdings Limited 的盈利品質評分是多少?
The United Laboratories International Holdings Limited 何時發布財報?
The United Laboratories International Holdings Limited 的預期收益是多少?
The United Laboratories International Holdings Limited 是否超出收益預期?
關鍵數據
前收市價
$11.35
開盤價
$11.3
當日範圍
$11.3 - $11.64
52週區間
$10.62 - $17.98
交易量
6.7M
平均成交量
9.5M
每股盈餘 (TTM)
1.88
股息收益率
--
市值
$22.8B
什麼是 UNITED LAB?
The United Laboratories International Holdings Ltd. is an investment company, which engages in manufacturing and selling medicine products. The company employs 17,400 full-time employees The company went IPO on 2007-06-15. The firm operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.